Home Newsfeeds Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Amazon Accused Of Raking In $1 Billion Through Deceptive Practices, According To FTC Suit

By Bibhu Pattnaik

November 4, 12:38 PM

The Federal Trade Commission (FTC) has leveled serious allegations against Amazon.com Inc. (NASDAQ: AMZN), claiming the e-commerce g

AMZN

Splash Beverage Group Announces Pricing Of $3.1M Public Offering Of 2,000,000 Share Of Common Stock At A Price Of $1.55 Per Share

By Benzinga Newsdesk

September 23, 8:17 AM

Fort Lauderdale, FL, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company" or "Splash Beverage Group"), a portfolio company of leading beverage

SBEV

IBio Divesting CDMO Business and CGMP Biologics Manufacturing Facility, to Result in About 50% Annualized Cost Savings; Commenced Workforce Reduction of Approximately 60% of Current Company Staffing Levels

By Charles Gross

November 3, 8:09 AM

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization (iBio CDMO, LLC) in order to complete its transformation into an antibody discovery and development company.

IBIO